TIAA CREF Investment Management LLC reduced its stake in shares of NanoString Technologies, Inc. (NASDAQ:NSTG) by 6.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,674 shares of the biotechnology company’s stock after selling 4,346 shares during the period. TIAA CREF Investment Management LLC’s holdings in NanoString Technologies were worth $1,305,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Wellington Management Group LLP raised its stake in shares of NanoString Technologies by 6.8% in the first quarter. Wellington Management Group LLP now owns 509,051 shares of the biotechnology company’s stock valued at $10,115,000 after buying an additional 32,541 shares during the last quarter. Spark Investment Management LLC raised its stake in shares of NanoString Technologies by 71.1% in the first quarter. Spark Investment Management LLC now owns 258,300 shares of the biotechnology company’s stock valued at $5,132,000 after buying an additional 107,300 shares during the last quarter. State Street Corp raised its stake in shares of NanoString Technologies by 16.7% in the fourth quarter. State Street Corp now owns 223,065 shares of the biotechnology company’s stock valued at $4,977,000 after buying an additional 31,911 shares during the last quarter. Strs Ohio raised its stake in shares of NanoString Technologies by 4.2% in the first quarter. Strs Ohio now owns 32,600 shares of the biotechnology company’s stock valued at $647,000 after buying an additional 1,300 shares during the last quarter. Finally, Columbus Circle Investors raised its stake in shares of NanoString Technologies by 27.1% in the first quarter. Columbus Circle Investors now owns 31,181 shares of the biotechnology company’s stock valued at $620,000 after buying an additional 6,649 shares during the last quarter. Hedge funds and other institutional investors own 90.10% of the company’s stock.

NanoString Technologies, Inc. (NSTG) traded down 1.05% during mid-day trading on Tuesday, hitting $14.10. The company had a trading volume of 6,805 shares. The firm’s 50 day moving average is $15.68 and its 200 day moving average is $17.61. The company’s market capitalization is $319.68 million. NanoString Technologies, Inc. has a 52 week low of $13.17 and a 52 week high of $23.45.

NanoString Technologies (NASDAQ:NSTG) last posted its quarterly earnings results on Tuesday, August 8th. The biotechnology company reported ($0.20) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.37) by $0.17. The business had revenue of $34.59 million for the quarter, compared to analysts’ expectations of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. On average, equities research analysts predict that NanoString Technologies, Inc. will post ($2.12) EPS for the current year.

TRADEMARK VIOLATION WARNING: “TIAA CREF Investment Management LLC Lowers Position in NanoString Technologies, Inc. (NSTG)” was reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.watchlistnews.com/tiaa-cref-investment-management-llc-lowers-position-in-nanostring-technologies-inc-nstg/1490243.html.

NSTG has been the topic of several research reports. Zacks Investment Research lowered NanoString Technologies from a “buy” rating to a “sell” rating in a research note on Thursday, July 6th. Morgan Stanley lowered NanoString Technologies from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $23.00 to $20.00 in a research note on Thursday, April 20th. BidaskClub lowered NanoString Technologies from a “sell” rating to a “strong sell” rating in a research note on Friday, July 28th. ValuEngine upgraded NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Cowen and Company reiterated a “buy” rating on shares of NanoString Technologies in a research note on Friday, July 14th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $18.50.

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Want to see what other hedge funds are holding NSTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NanoString Technologies, Inc. (NASDAQ:NSTG).

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.